Revolutions Medical Corporation ("RevMed" or
the "Company") (OTCBB: RMCP), producers of the RevVac safety syringe,
RevColor, RevDisplay and Rev3D MRI Technology, announced today that recent
mass media reports that CT scans cause cancer could rapidly elevate MRI as
the technology of choice for musculoskeletal scans and more. A resulting
spike in the number of MRI scans would not be met by an equal increase in
the number of radiologists, making the need to arm the existing ranks with
enhanced diagnostic tools a critical one.
According to the Archives of Internal Medicine
(http://archinte.ama-assn.org), radiation from CT scans done in 2007 alone
will cause 29,000 cancers (including 2,000 excess breast cancer cases) and
kill nearly 15,000 Americans. Read the following major media outlet
features:
MSNBC: http://www.msnbc.msn.com/id/34420356/ns/health-cancer/
Wall Street Journal:
http://online.wsj.com/article/SB126082398582691047.html
USA TODAY: http://www.usatoday.com/news/health/2009-12-15-radiation15_st_N.htm
"This is nothing short of a bombshell announcement for the MRI industry,"
stated Revolutions Medical CTO Richard Theriault. "MRI has long been a
potential replacement for CT scans across a variety of applications, but CT
has been the physicians' choice as the less expensive of the two options.
With the very real dangers of CT now exposed, patient safety will likely
trump cost concerns. Moreover, as insurance companies evaluate the
financial impact of a cancer case vs. a moderately more expensive scan, the
math may drive a mandated move to MRI.